Mitsubishi Tanabe Pharma/BioInvent

9/3/2009 9:30 AM

 

Lund-based biopharmaceutical company BioInvent has entered a joint R&D cooperation with Japan’s Mitsubishi Tanabe Pharma Corporation for the discovery and development of therapeutic antibodies.

Type of investment: Strategic alliance

Websites: www.bioinvent.com, www.mt-pharma.co.jp

Print Bookmark and Share

Contact

Peter Bramberg Head of Life Sciences

Phone
+46 8 402 78 45
Mobile
+46 70 667 31 00
Fax
+46 8 402 78 78
E-mail
Contact
Country
Sweden
Function:
Life Sciences